BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 24133451)

  • 1. Targeting cardiac β-adrenergic signaling via GRK2 inhibition for heart failure therapy.
    Cannavo A; Liccardo D; Koch WJ
    Front Physiol; 2013 Sep; 4():264. PubMed ID: 24133451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GRK2 inhibition in heart failure: something old, something new.
    Lymperopoulos A; Rengo G; Koch WJ
    Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.
    Vasudevan NT; Mohan ML; Gupta MK; Martelli EE; Hussain AK; Qin Y; Chandrasekharan UM; Young D; Feldman AM; Sen S; Dorn GW; Dicorleto PE; Naga Prasad SV
    Circulation; 2013 Jul; 128(4):377-87. PubMed ID: 23785004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms.
    Brinks H; Boucher M; Gao E; Chuprun JK; Pesant S; Raake PW; Huang ZM; Wang X; Qiu G; Gumpert A; Harris DM; Eckhart AD; Most P; Koch WJ
    Circ Res; 2010 Oct; 107(9):1140-9. PubMed ID: 20814022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRK2 as a novel gene therapy target in heart failure.
    Rengo G; Lymperopoulos A; Leosco D; Koch WJ
    J Mol Cell Cardiol; 2011 May; 50(5):785-92. PubMed ID: 20800067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta-adrenergic receptor kinase in heart failure.
    Petrofski JA; Koch WJ
    J Mol Cell Cardiol; 2003 Oct; 35(10):1167-74. PubMed ID: 14519424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRK2 blockade with βARKct is essential for cardiac β2-adrenergic receptor signaling towards increased contractility.
    Salazar NC; Vallejos X; Siryk A; Rengo G; Cannavo A; Liccardo D; De Lucia C; Gao E; Leosco D; Koch WJ; Lymperopoulos A
    Cell Commun Signal; 2013 Aug; 11():64. PubMed ID: 23984976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of sympathetic activity via adrenal-targeted GRK2 gene deletion attenuates heart failure progression and improves cardiac function after myocardial infarction.
    Lymperopoulos A; Rengo G; Gao E; Ebert SN; Dorn GW; Koch WJ
    J Biol Chem; 2010 May; 285(21):16378-86. PubMed ID: 20351116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preservation of myocardial beta-adrenergic receptor signaling delays the development of heart failure after myocardial infarction.
    White DC; Hata JA; Shah AS; Glower DD; Lefkowitz RJ; Koch WJ
    Proc Natl Acad Sci U S A; 2000 May; 97(10):5428-33. PubMed ID: 10779554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure.
    Eckhart AD; Ozaki T; Tevaearai H; Rockman HA; Koch WJ
    Mol Pharmacol; 2002 Apr; 61(4):749-58. PubMed ID: 11901213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of betaARK1 restores impaired biochemical beta-adrenergic receptor responsiveness but does not rescue CREB(A133) induced cardiomyopathy.
    Eckhart AD; Fentzke RC; Lepore J; Lang R; Lin H; Lefkowitz RJ; Koch WJ; Leiden JM
    J Mol Cell Cardiol; 2002 Jun; 34(6):669-77. PubMed ID: 12054854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-mediated inhibition of the b-adrenergic receptor kinase: a new therapeutic strategy for heart failure.
    Tevaearai HT; Eckhart AD; Koch WJ
    Minerva Cardioangiol; 2001 Dec; 49(6):389-94. PubMed ID: 11733734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade.
    Iaccarino G; Tomhave ED; Lefkowitz RJ; Koch WJ
    Circulation; 1998 Oct; 98(17):1783-9. PubMed ID: 9788834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting myocardial beta-adrenergic receptor signaling and calcium cycling for heart failure gene therapy.
    Pleger ST; Boucher M; Most P; Koch WJ
    J Card Fail; 2007 Jun; 13(5):401-14. PubMed ID: 17602988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphocyte levels of GRK2 (betaARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved beta-adrenergic signaling after mechanical unloading.
    Hata JA; Williams ML; Schroder JN; Lima B; Keys JR; Blaxall BC; Petrofski JA; Jakoi A; Milano CA; Koch WJ
    J Card Fail; 2006 Jun; 12(5):360-8. PubMed ID: 16762799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GRK2 as a therapeutic target for heart failure.
    Cannavo A; Komici K; Bencivenga L; D'amico ML; Gambino G; Liccardo D; Ferrara N; Rengo G
    Expert Opin Ther Targets; 2018 Jan; 22(1):75-83. PubMed ID: 29166798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.
    Raake PW; Vinge LE; Gao E; Boucher M; Rengo G; Chen X; DeGeorge BR; Matkovich S; Houser SR; Most P; Eckhart AD; Dorn GW; Koch WJ
    Circ Res; 2008 Aug; 103(4):413-22. PubMed ID: 18635825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure.
    Rengo G; Galasso G; Femminella GD; Parisi V; Zincarelli C; Pagano G; De Lucia C; Cannavo A; Liccardo D; Marciano C; Vigorito C; Giallauria F; Ferrara N; Furgi G; Filardi PP; Koch WJ; Leosco D
    Eur J Prev Cardiol; 2014 Jan; 21(1):4-11. PubMed ID: 23689525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inotropic peptide βARKct improves βAR responsiveness in normal and failing cardiomyocytes through G(βγ)-mediated L-type calcium current disinhibition.
    Völkers M; Weidenhammer C; Herzog N; Qiu G; Spaich K; Wegner FV; Peppel K; Müller OJ; Schinkel S; Rabinowitz JE; Hippe HJ; Brinks H; Katus HA; Koch WJ; Eckhart AD; Friedrich O; Most P
    Circ Res; 2011 Jan; 108(1):27-39. PubMed ID: 21106943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial GRK2 Reduces Fatty Acid Metabolism and β-Adrenergic Receptor-Mediated Mitochondrial Responses.
    Zhai R; Varner EL; Rao A; Karhadkar S; Di Carlo A; Snyder NW; Sato PY
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.